HDAC2 and cardiac hypertrophy: Through modulation of the AKT/mTOR pathway, palmatine reduced transcriptional levels of myocardial hypertrophy markers ANP and BNP, while inhibiting the hyperactivation of the HDAC2-KLF4/INPP5F pathway.